![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
GDUFA (U.S. Food and Drug Administration) View |
![]() |
GDUFA III: Controlled Correspondence (U.S. Food and Drug Administration) View |
![]() |
GDUFA III: Facility Readiness (U.S. Food and Drug Administration) View |
![]() |
GDUFA III MCRM External Training Presentation final (U.S. Food and Drug Administration) View |
![]() |
GDUFA II Training - DMF Update, Erin Skoda (U.S. Food and Drug Administration) View |
![]() |
GDUFA II Training IR and DR Letters, Michael Folkendt (U.S. Food and Drug Administration) View |
![]() |
ANDA Submissions – Amendments to Abbreviated New Drug Applications under GDUFA (U.S. Food and Drug Administration) View |
![]() |
GDUFA II (9/28) Generic Drugs Forum 2017 (U.S. Food and Drug Administration) View |
![]() |
GDUFA II Training - Pre ANDA Product Development Meetings, Robert Lionberger (U.S. Food and Drug Administration) View |
![]() |
GDUFA II Training - Pre ANDA Program Pre Submission Meetings, Robert Lionberger (U.S. Food and Drug Administration) View |